Chemiluminescent Point of Care Tests
Lead Participant:
INVITRON LIMITED
Abstract
Point of care tests (POCT) are rapid medical diagnostic tests designed to be carried out next to the patient. POCT devices produce results much faster than laboratory tests which enable physicians and nurses to act sooner and thus save lives, improve patient outcomes and reduce overall costs to the healthcare system. However, more widespread use of POCT is currently limited by the sensitivity of current devices. Invitron is developing a POCT technology using high sensitivity chemiluminescent compounds that will enable low cost, portable POCT devices to achieve the analytical sensitivity of laboratory analysers.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
INVITRON LIMITED | £143,605 | £ 86,163 |
  | ||
Participant |
||
AB AGRI LIMITED | ||
INNOVATE UK |
People |
ORCID iD |
Stuart Woodhead (Project Manager) |